Adenovirus particles (AdV)

Adenoviruses are non-enveloped, double-stranded DNA viruses belonging to the Adenoviridae family, which are responsible for a wide range of clinical manifestations including respiratory tract infections, conjunctivitis, and gastroenteritis (StatPearls, 2023). The phrase "non-specific physical interaction" refers to the initial binding events between the viral capsid and the host cell membrane or other surfaces, often mediated by electrostatic forces rather than specific protein-protein interactions (Journal of Virology, 2011). These interactions are critical for the virus's ability to navigate the extracellular environment and eventually engage specific receptors like the Coxsackievirus and Adenovirus Receptor (CAR) for entry (NIH, 2023). In drug development, targeting these physical interactions involves using neutralizing antibodies or polyanionic compounds that bind the capsid to prevent cell attachment. Furthermore, adenoviruses are frequently engineered as vectors for gene therapy and vaccines, where their physical interaction with the host immune system is a primary safety concern due to potential inflammatory responses (Nature Reviews Genetics, 2018). Therapeutic management of adenovirus infections typically involves antiviral drugs like cidofovir, which inhibits the viral DNA polymerase, though no drug is currently FDA-approved specifically for adenovirus (PubChem, 2024). Understanding these non-specific interactions is also vital for optimizing the stability and delivery of adenoviral vectors in clinical settings. Overall, the adenovirus particle serves as both a significant pathogen and a versatile tool in biotechnology, requiring careful modulation of its physical and biological properties.

Other names

AdenoviridaeAdenoviral capsidAdenovirus

Inhibition of viral DNA polymerase or physical neutralization of the viral capsid to prevent host cell entry.